{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:24Z","timestamp":1790140344363,"version":"4.0.1"},"reference-count":21,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Program funded by the Korea National Institute of Health","award":["2025-ER0902-01"],"award-info":[{"award-number":["2025-ER0902-01"]}]},{"name":"National Research Foundation of Korea grant funded by the Korean government","award":["RS-2024-00440477"],"award-info":[{"award-number":["RS-2024-00440477"]}]},{"name":"Regional Innovation System & Education grant through the Seoul RISE Centre, funded by the Ministry of Education and the Seoul Metropolitan Government","award":["2025-RISE-01-027-01"],"award-info":[{"award-number":["2025-RISE-01-027-01"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cryptogenic steatotic liver disease (SLD) remains undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated the clinical features and outcomes of cryptogenic SLD, operationalised as lean SLD without recorded cardiometabolic risk factors (CMRFs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Clinical characteristics were evaluated in the UK Biobank (UKB) magnetic resonance proton density fat fraction (MR-PDFF) cohort (SLD defined as PDFF \u22655%). Findings were assessed in a hepatic steatosis index-based UKB cohort and externally validated in three cross-sectional cohorts, including the National Health and Nutrition Examination Survey and Korean National Health Insurance Service (KNHIS) cohorts. Outcomes were examined using Cox regression in two longitudinal cohorts: the UKB hepatic steatosis index cohort and the KNHIS cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 30\u2009847 MR-PDFF participants, 1195 (3.4%) had non-obese SLD (body mass index &lt;25\u2009kg\/m\u00b2); 13.7% had cryptogenic SLD and 86.3% had lean metabolic dysfunction-associated SLD. Cryptogenic SLD showed less favourable metabolic and liver-related profiles than non-SLD\/no CMRF across cohorts. In cohort-specific analyses, cryptogenic SLD exhibited higher contrast-enhanced T1-weighted image values and an increased prevalence of PNPLA3 and TM6SF2 risk variants in the UKB MR-PDFF cohort. Higher fibrosis rates were observed in the magnetic resonance elastography cohort. In longitudinal analyses, cryptogenic SLD was associated with liver-related death in KNHIS (HR 2.5, 95% CI 1.4 to 4.3). A similar but imprecise association was observed in the UKB hepatic steatosis index cohort (HR 13.2, 95% CI 1.9 to 92.4). The KNHIS association persisted after stricter alcohol exclusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Operationally defined cryptogenic SLD accounted for a substantial proportion of lean SLD. Despite no recorded CMRFs, this phenotype was associated with liver injury markers and liver-related mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2026-339142","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:20:33Z","timestamp":1784222433000},"page":"gutjnl-2026-339142","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-048X","authenticated-orcid":false,"given":"Eileen Laurel","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)"},{"name":"Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-3572","authenticated-orcid":false,"given":"Hyo Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-5965","authenticated-orcid":false,"given":"Jonghyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-9498","authenticated-orcid":false,"given":"Joo Hyun","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHA University School of Medicine, Pocheon-si, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-055X","authenticated-orcid":false,"given":"Inseok","family":"Hwang","sequence":"additional","affiliation":[{"name":"Theragen Bio Co, Seongnam, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0238-7962","authenticated-orcid":false,"given":"Chan Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Theragen Bio Co, Seongnam, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2474-9339","authenticated-orcid":false,"given":"Sejung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Data Science, Gyeongkuk National University, Andong-si, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-8688","authenticated-orcid":false,"given":"Huiyul","family":"Park","sequence":"additional","affiliation":[{"name":"Family Medicine, Myoungjii Hospital, Hanyang University College of Medicine, Goyang, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1228-7021","authenticated-orcid":false,"given":"Ae Jeong","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Information Statistics, Gyeongkuk National University, Andong-si, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-6139","authenticated-orcid":false,"given":"Dae Won","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)"},{"name":"Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026081410301112000_gutjnl-2026-339142v2.1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cgh.2020.06.066","article-title":"Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases","volume":"19","author":"Weinberg","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322564"},{"key":"2026081410301112000_gutjnl-2026-339142v2.4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3350\/cmh.2024.0631","article-title":"Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations","volume":"31","author":"Danpanichkul","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3350\/cmh.2023.0250","article-title":"Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?","volume":"29","author":"Han","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12072-022-10324-9","article-title":"Is lean non-alcoholic fatty liver disease a distinct entity?","volume":"16","author":"Lin","year":"2022","journal-title":"Hepatol Int"},{"key":"2026081410301112000_gutjnl-2026-339142v2.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325102"},{"key":"2026081410301112000_gutjnl-2026-339142v2.8","unstructured":"National Center for Health Statistics . National health and nutrition examination survey 2017\u20132018 data files. Centers for Disease Control and Prevention, National Center for Health Statistics; 2017\u20132018. Available: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/search\/datapage.aspx?CycleBeginYear=2017"},{"key":"2026081410301112000_gutjnl-2026-339142v2.9","unstructured":"National Center for Health Statistics . National health and nutrition examination survey 2017\u20132018 examination data: liver ultrasound transient elastography (LUX_J). Centers for Disease Control and Prevention, National Center for Health Statistics; 2020. Available: https:\/\/wwwn.cdc.gov\/Nchs\/Data\/Nhanes\/Public\/2017\/DataFiles\/LUX_J.htm"},{"key":"2026081410301112000_gutjnl-2026-339142v2.10","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.3390\/jcm10194625","article-title":"Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver","volume":"10","author":"Park","year":"2021","journal-title":"JCM"},{"key":"2026081410301112000_gutjnl-2026-339142v2.11","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","article-title":"Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis","volume":"20","author":"Andersson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14625"},{"key":"2026081410301112000_gutjnl-2026-339142v2.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2026081410301112000_gutjnl-2026-339142v2.14","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.987"},{"key":"2026081410301112000_gutjnl-2026-339142v2.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133"},{"key":"2026081410301112000_gutjnl-2026-339142v2.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102503","article-title":"Gut Microbiota and Genetic Polymorphisms Appear to Drive Disease Expression of Nonalcoholic Fatty Liver Disease in Lean Individuals","volume":"15","author":"Anirvan","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"2026081410301112000_gutjnl-2026-339142v2.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908"},{"key":"2026081410301112000_gutjnl-2026-339142v2.18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1693123","article-title":"The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what\u2019s different?","volume":"16","author":"Dey","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026081410301112000_gutjnl-2026-339142v2.19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5009\/gnl230044","article-title":"Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort","volume":"18","author":"Park","year":"2024","journal-title":"Gut Liver"},{"key":"2026081410301112000_gutjnl-2026-339142v2.20","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16164","article-title":"Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease","volume":"45","author":"Seko","year":"2025","journal-title":"Liver Int"},{"key":"2026081410301112000_gutjnl-2026-339142v2.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03283-1"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-339142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:18Z","timestamp":1786728618000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-339142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":21,"alternative-id":["10.1136\/gutjnl-2026-339142"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-339142","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}